دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Platinum Hall of Fame
doi : 10.1016/j.eururo.2024.04.007
Volume 85, Issue 6, June 2024, Pages e151-e161
Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study
Manuel Weber a †, Wolfgang P. Fendler a †, Aravind S. Ravi Kumar b c d, Jeremie Calais e, Johannes Czernin e, Harun Ilhan f, Fred Saad g, Alexander Kretschmer h i, Turkay Hekimsoy j, Sabine D. Brookman-May h i, Suneel D. Mundle k, Eric J. Small l, Matthew R. Smith m, Paola M. Perez l, Thomas A. Hope l, Ken Herrmann a, Michael S. Hofman b c d, Matthias Eiber j ‡, Boris A. Hadaschik n ‡
doi : 10.1016/j.eururo.2024.01.019
Volume 85, Issue 6, June 2024, Pages 511-516
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial
John Nikitas a, Matthew Rettig b c, John Shen b, Robert Reiter b, Alan Lee a, Michael L. Steinberg a, Luca F. Valle a d, Ankush Sachdeva b, Tahmineh Romero e, Jeremie Calais f, Johannes Czernin f, Nicholas G. Nickols a d †, Amar U. Kishan a â€
doi : 10.1016/j.eururo.2024.01.021
Volume 85, Issue 6, June 2024, Pages 517-520
Oligometastatic Recurrent Prostate Cancer: Whether To Intensify Treatment or Not
Gert De Meerleer a, Steven Joniau b, Jan Benijts c, Kato Rans a
doi : 10.1016/j.eururo.2024.03.017
Volume 85, Issue 6, June 2024, Pages 521-522
Identification of Lineage-specific Transcriptional Factor–defined Molecular Subtypes in Small Cell Bladder Cancer
Mingxiao Feng a b, Andres Matoso a b c d, Gabriel Epstein a b c, Megan Fong a b, Yong Hyun Park a e, Andrew Gabrielson a b, Sunil Patel a b, Bagdan Czerniak f, Eva Compérat g, Jeannie Hoffman-Censits b c, Max Kates a b c, Seungchan Kim h, David McConkey a b c, Woonyoung Choi a b
doi : 10.1016/j.eururo.2023.05.023
Volume 85, Issue 6, June 2024, Pages 523-526
The Impact of Lineage-specific Transcriptional Factors in Small-cell Bladder Cancer in the Patient Selection Process in Future Clinical Trials
Giuseppe Basile a, Francois Audenet b, Thomas Seisen a c, Benjamin Pradere d
doi : 10.1016/j.eururo.2023.07.003
Volume 85, Issue 6, June 2024, Pages 527-528
Thulium Fiber Laser Versus Holmium:Yttrium Aluminum Garnet for Lithotripsy: A Systematic Review and Meta-analysis
Alessandro Uleri a, Alba Farré a, Paula Izquierdo a, Oriol Angerri a, Andrés Kanashiro a, Josep Balaña a, Vineet Gauhar b, Daniele Castellani c, Francisco Sanchez-Martin a, Manoj Monga d, Adolfo Serrano e, Mantu Gupta f, Michael Baboudjian g, Andrea Gallioli a, Alberto Breda a, Esteban Emiliani a
doi : 10.1016/j.eururo.2024.01.011
Volume 85, Issue 6, June 2024, Pages 529-540
Thulium Fiber Laser Versus Holmium:Yttrium Aluminum Garnet for Lithotripsy: Which Is the Winner?
Olivier Traxer a, Margaret Pearle b
doi : 10.1016/j.eururo.2024.02.023
Volume 85, Issue 6, June 2024, Pages 541-542
Summary of the 2024 Update of the European Association of Urology Guidelines on Neuro-urology
Andrea M. Sartori a b c, Thomas M. Kessler a, David M. Castro-DÃaz d, Peter de Keijzer e, Giulio Del Popolo f, Hazel Ecclestone g, Dennis Frings h, Jan Groen h, Rizwan Hamid i, Gilles Karsenty j, Stefania Musco f, Bárbara Padilla-Fernández d, Jürgen Pannek k l, Natasha Schouten e, Angela van der Vorm e, Bertil F.M. Blok h
doi : 10.1016/j.eururo.2024.03.026
Volume 85, Issue 6, June 2024, Pages 543-555
Orthotopic Robot-assisted Kidney Transplantation: Surgical Technique and Preliminary Results
Francesc Vigués a, Begoña Etcheverry a, José I. Perez Reggeti a, Josep Maria Gaya b, Angelo Territo b, Andrea Gallioli b, Camille Berquin b c, Giuseppe Basile b d, José F. Suárez a, Maria Fiol a, Oscar Buisan a, LluÃs Riera a, Thomas Prudhomme e, Nicolas Doumerc e, Alessio Pecoraro b f †, Alberto Breda b †, European Association of Urology Robotic Urology Section Robot-assisted Kidney Transplantation Working Group
doi : 10.1016/j.eururo.2024.03.037
Volume 85, Issue 6, June 2024, Pages 556-564
Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer
Annika Herlemann a b, Janet E. Cowan a, Samuel L. Washington 3rd a c, Anthony C. Wong d, Jeanette M. Broering a, Peter R. Carroll a, Matthew R. Cooperberg a c
doi : 10.1016/j.eururo.2023.09.024
Volume 85, Issue 6, June 2024, Pages 565-573
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy
Jonathan E. Rosenberg a †, Ronac Mamtani b †, Guru P. Sonpavde c, Yohann Loriot d, Ignacio Duran e, Jae-Lyun Lee f, Nobuaki Matsubara g, Christof Vulsteke h, Daniel Castellano i, Srikala S. Sridhar j, Helle Pappot k, Howard Gurney l, Jens Bedke m, Michiel S. van der Heijden n, Luca Galli o, Bhumsuk Keam p, Naoya Masumori q, Johannes Meran r, Peter H. O'Donnell s, Se Hoon Park t…Daniel P. Petrylak bb
doi : 10.1016/j.eururo.2024.01.007
Volume 85, Issue 6, June 2024, Pages 574-585
Re: Assessment of PD-L1, TROP2, and NECTIN-4 Expression in Penile Squamous Cell Carcinoma
Johannes Linxweiler a †, Niklas Klümper b †, Jan Mink a, Markus Eckstein c, Kerstin Junker a
doi : 10.1016/j.eururo.2024.03.001
Volume 85, Issue 6, June 2024, Pages 586-587
Re: BilR is a Gut Microbial Enzyme that Reduces Bilirubin to Urobilinogen
Prokar Dasgupta *
doi : 10.1016/j.eururo.2024.03.004
Volume 85, Issue 6, June 2024, Pages 587-588
Re: First-in-human Evaluation of a Prostate-specific Membrane Antigen–targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy
Maximilian Burger *
doi : 10.1016/j.eururo.2024.03.003
Volume 85, Issue 6, June 2024, Pages 588-589
Re: Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population
Rodolfo Montironi a, Alessia Cimadamore b, Gianluca Giannarini c, Alessandro Crestani c, Antonio Lopez-Beltran d, Liang Cheng e
doi : 10.1016/j.eururo.2024.02.019
Volume 85, Issue 6, June 2024, Pages 589-590
Re: Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence
Martijn A.C. Smits, John P.F.A. Heesakkers
doi : 10.1016/j.eururo.2024.01.027
Volume 85, Issue 6, June 2024, Pages 590-591
Re: Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
Constantin Tilgener, Jens Bedke
doi : 10.1016/j.eururo.2024.02.020
Volume 85, Issue 6, June 2024, Pages 591-592
Sexual and Moral Harassment of French Urologists in Training and Barriers to Reporting: Results from a National Survey
Emilien Seizilles de Mazancourt a, Juliette Cotte b, Caroline Plassais c, Ugo Pinar b, Anna Goujon d, Fayek Taha e, Denis Seguier f, Truong An Nguyen g, Francois Lannes h, Claire Deleuze i, Florian Bardet j, Kevin Kaulanjan i
doi : 10.1016/j.eururo.2023.10.020
Volume 85, Issue 6, June 2024, Pages e162-e163
Re: Bertrand Tombal, Sean Collins, Alicia K. Morgans, et al. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. Eur Urol 2023;84:579–87
Hannah L. Rush a b, Duncan C. Gilbert a, Ruth E. Langley a
doi : 10.1016/j.eururo.2024.03.024
Volume 85, Issue 6, June 2024, Pages e164-e165
Re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63–71
Angela Estevez, Phillip Kim, Peter Chang, Andrew A. Wagner
doi : 10.1016/j.eururo.2024.02.026
Volume 85, Issue 6, June 2024, Page e166
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner’s Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63–71
Giuseppe Basile a b, Alessandro Larcher a, Arturo Chiti c, Alberto Breda b, Umberto Capitanio a
doi : 10.1016/j.eururo.2024.03.022
Volume 85, Issue 6, June 2024, Pages e167-e168
Re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-Assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. 2024;85:445–456
Alessandro Guercio a, Antonio Franco a, Elisa Mancini a, Riccardo Lombardo a, Francesco Curto b, Giorgio Franco a, Cosimo De Nunzio a
doi : 10.1016/j.eururo.2024.02.025
Volume 85, Issue 6, June 2024, Pages e169-e170
Reply to Alessandro Guercio, Antonio Franco, Elisa Mancini, et al’s Letter to the Editor re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. 2024;85:445–456
Roxana Ramos, Jihad Kaouk
doi : 10.1016/j.eururo.2024.03.020
Volume 85, Issue 6, June 2024, Pages e171-e172
Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7
Richard J. Wassersug a, Paul F. Schellhammer b, Erik Wibowo a c
doi : 10.1016/j.eururo.2024.02.022
Volume 85, Issue 6, June 2024, Pages e173-e174
Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo’s Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7
Christopher J. Logothetis, Andrew W. Hahn
doi : 10.1016/j.eururo.2024.03.019
Volume 85, Issue 6, June 2024, Page e175
Re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108
Miao Liu †, Peng Chen †, Tao Li
doi : 10.1016/j.eururo.2023.11.027
Volume 85, Issue 6, June 2024, Pages e176-e177
Reply to Lin Ding, Bin Yang, and Xudong Yao’s Letter to the Editor re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108
Fred Saad a, Paula del Rosario b, Noel W. Clarke c
doi : 10.1016/j.eururo.2023.11.015
Volume 85, Issue 6, June 2024, Pages e178-e179
Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines� [Eur. Urol. 85 (2024) 17–31]
J. Alfred Witjes a, Harman Max Bruins b, Albert Carrión c, Richard Cathomas d, Eva Compérat e, Jason A. Efstathiou f, Rainer Fietkau g, Georgios Gakis h, Anja Lorch i, Alberto Martini j k, Laura S. Mertens l, Richard P. Meijer m, Matthew I. Milowsky n, Yann Neuzillet o, Valeria Panebiaco p, John Redlef q, Michael Rink r, Mathieu Rouanne o, George N. Thalmann s, Sæbjørn Sæbjørnsen q…Antoine G. van der Heijden a
doi : 10.1016/j.eururo.2024.03.002
Volume 85, Issue 6, June 2024, Page e180
Congress Calendar
doi : 10.1016/j.eururo.2024.04.006
Volume 85, Issue 6, June 2024, Pages e181-e182
Acknowledgement to Reviewers
doi : 10.1016/j.eururo.2024.04.002
Volume 85, Issue 6, June 2024, Pages e183-e186
